Glucose deprivation-induced metabolic oxidative stress and cancer therapy
Open Access
- 1 January 2009
- journal article
- review article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 5 (9), 2-6
- https://doi.org/10.4103/0973-1482.55133
Abstract
Cancer cells (vs. normal cells) demonstrate evidence of oxidative stress, increased glycolysis, and increased pentose cycle activity. The oxidative stress in cancer cells has been hypothesized to arise from mitochondrial dysfunction leading to increased levels of hydroperoxides, and cancer cells have been proposed to compensate for this defect by increasing glucose metabolism. Glucose metabolism has also been shown to play a role in hydroperoxide detoxification via the formation of pyruvate (from glycolysis) and NADPH (from the pentose cycle). Furthermore, in cancer cells, glucose deprivation as well as treatment with 2-deoxyglucose (2 DG) has been shown to induce oxidative stress and cytotoxicity. Additionally, transformed cells have been shown to be more susceptible to glucose deprivation (and 2DG-)-induced cytotoxicity and oxidative stress than untransformed cells. These results support the hypothesis that cancer cells have a defect in mitochondrial respiration leading to increased steady state levels of O 2 - and H 2 O2 , and glucose metabolism is increased to compensate for this defect. The application of these findings to developing cancer therapies using 2DG combined with inhibitors of hydroperoxide metabolism to induce radio/chemosensitization is discussed, as well as the possibility that FDG-PET imaging may predict tumor responses to these therapies.Keywords
This publication has 45 references indexed in Scilit:
- FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Evaluation of 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography With Histopathologic Correlation in the Initial Staging of Head and Neck CancerAnnals of Surgery, 2002
- Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression of γ-glutamylcysteine synthetaseFree Radical Biology & Medicine, 2002
- FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinomaHead & Neck, 2002
- Positron emission tomography in the evaluation of stage III and IV head and neck cancerHead & Neck, 2001
- Positron Emission Tomography: An Independent Indicator of Radiocurability in Head and Neck CarcinomasAmerican Journal of Clinical Oncology, 2000
- Cisplatin resistance and oncogenes - a reviewAnti-Cancer Drugs, 2000
- Surveillance for Recurrent Head and Neck Cancer Using Positron Emission TomographyJournal of Clinical Oncology, 2000
- Glucose Deprivation‐Induced Oxidative Stress in Human Tumor Cells: A Fundamental Defect in Metabolism?Annals of the New York Academy of Sciences, 2000
- Inhibition of glutathione synthesis as a chemotherapeutic strategy for trypanosomiasis.The Journal of Experimental Medicine, 1981